Amanote Research
Register
Sign In
Blockade of Angiotensin II Receptors Reduces the Expression of Receptors for Advanced Glycation End Products in Human Endothelial Cells
Arteriosclerosis, Thrombosis, and Vascular Biology
- United States
doi 10.1161/01.atv.0000239569.99126.37
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cardiovascular Medicine
Cardiology
Date
October 1, 2006
Authors
M. Fujita
Publisher
Ovid Technologies (Wolters Kluwer Health)
Related search
FEEL-1 and FEEL-2 Are Endocytic Receptors for Advanced Glycation End Products
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Regulation of Vascular Endothelial Growth Factor Expression by Advanced Glycation End Products
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Angiotensin II-elicited Signal Transduction via AT1 Receptors in Endothelial Cells
British Journal of Pharmacology
Pharmacology
Regulation of Advanced Glycation End Product (AGE) Receptors and Apoptosis by AGEs in Osteoblast-Like Cells
Molecular and Cellular Biochemistry
Medicine
Clinical Biochemistry
Cell Biology
Molecular Biology
Toll-Like Receptors, Triggering Receptor Expressed on Myeloid Cells Family Members and Receptor for Advanced Glycation End-Products in Allergic Airway Inflammation
Expert Review of Respiratory Medicine
Immunology
Public Health
Allergy
Environmental
Pulmonary
Respiratory Medicine
Occupational Health
Upregulation of Angiotensin-Converting Enzyme 2 After Myocardial Infarction by Blockade of Angiotensin II Receptors
Hypertension
Internal Medicine
Zinc Against Advanced Glycation End Products
Clinical and Experimental Pharmacology and Physiology
Physiology
Pharmacology
Correlation Between Advanced Glycation End-Products and the Expression of Fatty Inflammatory Factors in Type II Diabetic Cardiomyopathy
Bosnian Journal of Basic Medical Sciences
Medicine
Human Aortic Smooth Muscle Cells Containing Angiotensin II Type 1 Receptors.
The Japanese Journal of Pharmacology
